UC San Diego and Genentech scientists develop potentially disruptive antibody sequencing technology

Bioinformatics researchers at the University of California, San Diego and Genentech have developed a new, quicker way to sequence monoclonal antibodies - a process that is many times faster than the sequencing technology typically used by academic and industry researchers today.

Read the whole article on Physorg

More from Physorg